Symptom Response Dynamics for Personalised Therapy with Subcutaneous Infliximab in Crohn's Disease: Insights from the Randomised, Placebo-Controlled, Phase 3 LIBERTY-CD Trial.
Saved in:
| Title: | Symptom Response Dynamics for Personalised Therapy with Subcutaneous Infliximab in Crohn's Disease: Insights from the Randomised, Placebo-Controlled, Phase 3 LIBERTY-CD Trial. |
|---|---|
| Authors: | Schreiber S; Department of Medicine I, University Hospital Schleswig-Holstein, Kiel University, Rosalind-Franklin-Strasse 12, 24105, Kiel, Germany. s.schreiber@mucosa.de., Sands BE; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Danese S; Department of Gastroenterology, IRCCS San Raffaele Hospital and Vita-Salute University, Milan, Italy., Loftus EV Jr; Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA., Jeong AL; Global Medical Division, Celltrion Inc., Incheon, Republic of Korea., Kim DH; Global Medical Division, Celltrion Inc., Incheon, Republic of Korea., Lee YN; Global Medical Division, Celltrion Inc., Incheon, Republic of Korea., Colombel JF; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. jean-frederic.colombel@mssm.edu. |
| Source: | Advances in therapy [Adv Ther] 2026 Jun; Vol. 43 (6), pp. 2510-2526. Date of Electronic Publication: 2026 Mar 30. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study |
| Journal Info: | Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41910935 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Symptom Response Dynamics for Personalised Therapy with Subcutaneous Infliximab in Crohn's Disease: Insights from the Randomised, Placebo-Controlled, Phase 3 LIBERTY-CD Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Schreiber+S%22">Schreiber S</searchLink>; Department of Medicine I, University Hospital Schleswig-Holstein, Kiel University, Rosalind-Franklin-Strasse 12, 24105, Kiel, Germany. s.schreiber@mucosa.de.<br /><searchLink fieldCode="AU" term="%22Sands+BE%22">Sands BE</searchLink>; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.<br /><searchLink fieldCode="AU" term="%22Danese+S%22">Danese S</searchLink>; Department of Gastroenterology, IRCCS San Raffaele Hospital and Vita-Salute University, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Loftus+EV+Jr%22">Loftus EV Jr</searchLink>; Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Jeong+AL%22">Jeong AL</searchLink>; Global Medical Division, Celltrion Inc., Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+DH%22">Kim DH</searchLink>; Global Medical Division, Celltrion Inc., Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+YN%22">Lee YN</searchLink>; Global Medical Division, Celltrion Inc., Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Colombel+JF%22">Colombel JF</searchLink>; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. jean-frederic.colombel@mssm.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2026 Jun; Vol. 43 (6), pp. 2510-2526. <i>Date of Electronic Publication: </i>2026 Mar 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41910935 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12325-026-03533-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2510 Titles: – TitleFull: Symptom Response Dynamics for Personalised Therapy with Subcutaneous Infliximab in Crohn's Disease: Insights from the Randomised, Placebo-Controlled, Phase 3 LIBERTY-CD Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Schreiber S – PersonEntity: Name: NameFull: Sands BE – PersonEntity: Name: NameFull: Danese S – PersonEntity: Name: NameFull: Loftus EV Jr – PersonEntity: Name: NameFull: Jeong AL – PersonEntity: Name: NameFull: Kim DH – PersonEntity: Name: NameFull: Lee YN – PersonEntity: Name: NameFull: Colombel JF IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1865-8652 Numbering: – Type: volume Value: 43 – Type: issue Value: 6 Titles: – TitleFull: Advances in therapy Type: main |
| ResultId | 1 |
